TFF Pharmaceuticals
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da TFF Pharmaceuticals
- Harlan Weisman, Vice Chairman of the Board and Chief Executive Off...
- Stephen Rocamboli, Director
- Robert Mills, Director
Recentes movimentos de executivos em TFF Pharmaceuticals
- Thomas King, ingressou na Companhia como Director (Notícia publicada em 14 de dezembro de 2023).
- Catherine Lee, ingressou na Companhia como Director (Notícia publicada em 1 de dezembro de 2023).
Criar um alerta
para seguir os movimentos de executivos da TFF Pharmaceuticals.
Farmacêutica
TFF Pharmaceuticals possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Oral Presentation of Interim Data from the Phase 2 Study of Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection at the 44th Annual International Society for Heart and Lung Transplantation (I
- TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Updated Data from the Tacrolimus Inhalation Powder (TFF TAC) and Voriconazole Inhalation Powder (TFF VORI) Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Update on Clinical Programs | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | TFF Pharmaceuticals
- TFF Pharmaceuticals to Participate in the 36th Annual Roth Conference – March 17-19, 2024 | TFF Pharmaceuticals
- TFF Pharmaceuticals to Present Data from Phase 2 Trial of Voriconazole Inhalation Powder (TFF VORI) for the Treatment of Invasive Pulmonary Aspergillosis at the 11th Advances Against Aspergillosis & Mucormycosis Conference | TFF Pharmaceuticals
- TFF Pharmaceuticals Announces Acceptance of Late-Breaking Abstract for Presentation at the 44th Annual International Society for Heart and Lung Transplantation (ISHLT) 2024 Meeting | TFF Pharmaceuticals
- View more press releases Close
Redes sociais sobre TFF Pharmaceuticals
- TFF Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- TFF Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Harlan Weisman 
Ligue para a TFF Pharmaceuticals em +1 737...
